Trade Summary

1 week ago, Farnum Rhonda, serving as SVP, COMM, MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH), sold 31,067 shares at $13.96 per share, for a total transaction value of $433,637.00. Following this transaction, Farnum Rhonda now holds 232,699 shares of TBPH.

This sale represents a 12.00% decrease in Farnum Rhonda's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 2 days after the trade was made.

Theravance Biopharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.